bioRxiv ScienceSearch

Biology subjects

Verbanck, M.

Publications and source records attributed to Verbanck, M..

3 recordsLinked to original sources

The landscape of pervasive horizontal pleiotropy in human genetic variation is driven by extreme polygenicity of human traits and diseases

Horizontal pleiotropy, where one variant has independent effects on multiple traits, is important for our understanding of the genetic architecture of human phenotypes. We develop a method to quantify horizontal pleiotropy using genome-wide association summary statistics and apply it to 372 heritable phenotypes measured in 361,194 UK Biobank individuals. Horizontal pleiotropy is pervasive throughout the human genome, prominent among highly polygenic phenotypes, and enriched in active regulatory regions. Our results highlight the central role horizontal pleiotropy plays in the genetic architecture of human phenotypes. The HOrizontal Pleiotropy Score (HOPS) method is available on Github at https://github.com/rondolab/HOPS.

genetics

Genetic Diversity Turns a New PAGE in Our Understanding of Complex Traits

Summary/AbstractGenome-wide association studies (GWAS) have laid the foundation for investigations into the biology of complex traits, drug development, and clinical guidelines. However, the dominance of European-ancestry populations in GWAS creates a biased view of the role of human variation in disease, and hinders the equitable translation of genetic associations into clinical and public health applications. The Population Architecture using Genomics and Epidemiology (PAGE) study conducted a GWAS of 26 clinical and behavioral phenotypes in 49,839 non-European individuals. Using strategies designed for analysis of multi-ethnic and admixed populations, we confirm 574 GWAS catalog variants across these traits, and find 38 secondary signals in known loci and 27 novel loci. Our data shows strong evidence of effect-size heterogeneity across ancestries for published GWAS associations, substantial benefits for fine-mapping using diverse cohorts, and insights into clinical implications. We strongly advocate for continued, large genome-wide efforts in diverse populations to reduce health disparities.

genetics

Widespread pleiotropy confounds causal relationships between complex traits and diseases inferred from Mendelian randomization

A fundamental assumption in inferring causality of an exposure on complex disease using Mendelian randomization (MR) is that the genetic variant used as the instrumental variable cannot have pleiotropic effects. Violation of this no pleiotropy assumption can cause severe bias. Emerging evidence have supported a role for pleiotropy amongst disease-associated loci identified from GWA studies. However, the impact and extent of pleiotropy on MR is poorly understood. Here, we introduce a method called the Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO) test to detect and correct for pleiotropy in multi-instrument summary-level MR testing. We show using simulations that existing approaches are less sensitive to the detection of pleiotropy when it occurs in a subset of instrumental variables, as compared to MR-PRESSO. Next, we show that pleiotropy is widespread in MR, occurring in 41% amongst significant causal relationships (out of 4,250 MR tests total) from pairwise comparisons of 82 complex traits and diseases from summary level genome-wide association data. We demonstrate that pleiotropy causes distortion between-168% and 189% of the causal estimate in MR. Furthermore, pleiotropy induces false positive causal relationships-defined as those causal estimates that were no longer statistically significant in the pleiotropy corrected MR test but were previously significant in the naive MR test-in up to 10% of the MR tests using a P < 0.05 cutoff that is commonly used in MR studies. Finally, we show that MR-PRESSO can correct for distortion in the causal estimate in most cases. Our results demonstrate that pleiotropy is widespread and pervasive, and must be properly corrected for in order to maintain the validity of MR.

genomics